Comparison of acute hemodynamic effects of aerosolized and intravenous Iloprost in secondary pulmonary hypertension in children with congenital heart disease

American Journal of Cardiology

Volumn 92, Issue 8, 2003, Pages 1007-1009

  Hallioglu, Olgu ^a   Dilber, Embiya ^a   Celiker, Alpay ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST;

ARTICLE; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; HEART CATHETERIZATION; HEMODYNAMIC MONITORING; HUMAN; INFANT; LUNG HEMODYNAMICS; NEBULIZATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIDE EFFECT; VASCULAR RESISTANCE;

EID: 0141594875     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00991-3     Document Type: Article

References (10)

1. Olschewski H., Walmrath D., Schermuly R., Ghofrani A., Grimminger F., Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med. 124:1996;820-824.
2. Olschewski H., Ghofrani H.A., Walmrath D., Schermuly R., Temmesfeld-Wollbruck B., Grimminger F., Seeger W. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med. 160:1999;600-607.
3. Hoeper M.M., Olschewski H., Ghofrani H.A., Wilkens H., Winkler J., Borst M.M., Niedermeyer J., Fabel H., Seeger W. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol. 35:2000;176-182.
4. Olschewski H., Ghofrani H.A., Schmehl T., Winkler J., Wilkens H., Hoper M.M., Behr J., Kleber F.X., Seeger W. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group. Ann Intern Med. 132:2000;435-443.
5. Hoeper M.M., Schwarze M., Ehlerding S., Adler-Schuermeyer A., Spiekerkoetter E., Niedermeyer J., Hamm M., Fabel H. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med. 342:2000;1866-1870.
6. Rimensberger P.C., Spahr-Schopfer I., Berner M., Jaeggi E., Kalangos A., Friedli B., Beghetti M. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease vasodilator capacity and cellular mechanisms . Circulation. 103:2001;544-548.
7. Zwissler B., Rank N., Jaenicke U., Schurle B., Welte M., Reichart B., Netz H., Messmer K., Peter K. Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology. 82:1995;1512-1516.
8. Max M., Rossaint R. Inhaled prostacyclin in the treatment of pulmonary hypertension. Eur J Pediatr. 158:(suppl 1):1999;S23-S26.
9. Zwissler B., Rank N., Jaenicke U., Schurle B., Welte M., Reichart B., Netz H., Messmer K., Peter K. Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology. 82:1995;1512-1516.
10. Wensel R., Opitz C.F., Ewert R., Bruch L., Kleber F.X. Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension. Circulation. 101:2000;2388-2392.